Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
K
Kadri, Sabah
Lurie Children's Hospital of Chicago
AMP Clinical Bioinformatician Body of Knowledge
Location: 211 - 214, Level 2
Sabah Kadri
Kalman, Lisa
Centers for Disease Control and Prevention
AMP/ACMG/CPIC/CAP/DPWG/ESPT/PharmGKB/PharmVar DPYD Genotyping Recommendations
Location: 220 - 222, Level 2
Lisa Kalman
Kalra, Dishant
Transforming Heme Diagnostics: Harnessing the Power of NGS in the Evolving Landscape
Location: 212 & 213, Level 2
Dishant Kalra
Kalyan, Shirin
Transforming Heme Diagnostics: Harnessing the Power of NGS in the Evolving Landscape
Location: 212 & 213, Level 2
Shirin Kalyan
Kanagal-Shamanna, Rashmi
The University of Texas MD Anderson Cancer Center
Clonal Hematopoiesis: Background and Clinical Significance
Location: 109 & 110, Level 1
Rashmi Kanagal-Shamanna
Kanwar, Nisha
Mayo Clinic
Liquid Biopsy Guides Diagnostic Algorithm in a Case With Two Metasynchronous Primary Tumors
Location: 211 - 214, Level 2
Nisha Kanwar
Karunamurthy, Arivarasan
University of Pittsburgh Medical Center
Case Studies in Solid Tumors II
Location: 118 - 120, Level 1
Arivarasan Karunamurthy
Human Tumor Atlas Network: Mapping Tumor Transitions at Molecular Resolution
Location: Ballroom, Level 1
Arivarasan Karunamurthy
Radiogenomics: Integrating Molecular and Imaging Data in Cancer Diagnosis
Location: 118 - 120, Level 1
Arivarasan Karunamurthy
Unveiling Viral Associations in Human Cancer Using Genomic Data
Location: 211 - 214, Level 2
Arivarasan Karunamurthy
Kaul, Karen
NorthShore Hospitals / Endeavor Health
Professional Relations Committee (PRC) Discusses AMP Lawsuit Against FDA Challenging Oversight of Lab Developed Testing Procedures
Location: 118 - 120, Level 1
Karen Kaul
Khalil, Farah
Integrating Comprehensive Biomarker Testing for Precision Treatment
Location: Innovation Spotlight Stage #2
Farah Khalil
Kiel, MD, Phd, Mark
Comprehensive Curated Content to Improve Detection and Reporting of Somatic and Germline Variants for WGS and Large Cancer Gene Panels
Location: 214, Level 2
Mark Kiel, MD, Phd
Kim, Annette
University of Michigan
Fireside Chat: LDT Compliance in an Uncertain Environment
Location: 211, Level 2
Annette Kim
Kirschner, Sophie
AstraZeneca
Utilizing Pillar Biosciences' Rapid oncoRevealTM 4-Gene Methylation Panel to Guide the Expanded Use of PARPi Therapy In Breast Cancer Patients
Location: 111 & 112, Level 1
Sophie Kirschner
Klee, Eric
Mayo Clinic
How Is AMP Helping You Develop and Maintain Your Subject Matter Expertise?
Location: Innovation Spotlight Stage #1
Eric Klee
Klein, Roger
Center for Law, Science and Innovation, ASU Law School
Professional Relations Committee (PRC) Discusses AMP Lawsuit Against FDA Challenging Oversight of Lab Developed Testing Procedures
Location: 118 - 120, Level 1
Roger Klein
Klemm, Florian
SOPHiA GENETICS
Strategic Collaborations for Expanding Liquid Biopsy Use Globally
Location: 214, Level 2
Florian Klemm
Klonoski, Joshua
University of Colorado
Distinct Atypical Meningiomas Hiding in Plain Sight, Out SMARC’d by SMARCB1
Location: 118 - 120, Level 1
Joshua Klonoski
Ko, Heidi
Labcorp Oncology
A Panel Discussion on Challenges and Practice Gaps Affecting Implementation of Oncology Precision Medicine
Location: 212 & 213, Level 2
Heidi Ko
Kolhe, Ravindra
Augusta University
Molecular Profiling in Difficult Samples From NSCLC Quickly and Cost-Effectively
Location: 114 & 115, Level 1
Ravindra Kolhe
Konnick, Eric
University of Washington
Professional Relations Committee (PRC) Discusses AMP Lawsuit Against FDA Challenging Oversight of Lab Developed Testing Procedures
Location: 118 - 120, Level 1
Eric Konnick
